Crinetics Pharmaceuticals Inc buy JPMorgan Chase & Co.
Start price
24.09.25
/
50%
€30.40
Target price
24.09.26
€44.06
Performance (%)
21.71%
Price
20.02.26
€37.00
Summary
This prediction is currently active. The prediction currently has a performance of 21.71%. This prediction currently runs until 24.09.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Crinetics Pharmaceuticals Inc | 2.778% | 2.778% |
| iShares Core DAX® | 1.432% | 2.628% |
| iShares Nasdaq 100 | 1.892% | -0.458% |
| iShares Nikkei 225® | -1.619% | 11.097% |
| iShares S&P 500 | 1.921% | 1.159% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals (NASDAQ:CRNX) had its price target lowered by analysts at JPMorgan Chase & Co. from $53.00 to $52.00. They now have an "overweight" rating on the stock.
Ratings data for CRNX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€44.60
09.07.24
09.07.24
€49.94
09.07.25
09.07.25
-39.01%
10.07.25
10.07.25
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€27.40
20.11.23
20.11.23
€32.04
20.11.24
20.11.24
100.73%
21.11.24
21.11.24